homocysteine has been researched along with cardiovascular agents in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimayuga, C; Hudaihed, A; Katz, SD; Zheng, H | 1 |
| Joseph, J; Kennedy, RH; Owings, R; Shekhawat, N | 1 |
| Hofmann, T | 1 |
| Champion, HC; Claeys, MJ; Kass, DA; Moens, AL; Timmermans, JP; Vrints, CJ | 1 |
| Loftus, I; Thompson, M | 1 |
| Einollahi, B; Farhangi, S; Farjad, R; Firouzan, A; Kalantar, A; Kardavani, B; Khatami, F; Nafar, M; Pour-Reza-Gholi, F | 1 |
| Cao, Y; Chai, JG; Chen, YC; Liu, XD; Liu, XQ; Ma, C; Shao, JP; Zhao, J; Zhou, J | 1 |
| Armon, MP; Clark, A; Finglas, PM; Jennings, B; Khandanpour, N; Meyer, FJ; Willis, G | 1 |
| Guo, H; Liu, L; Shi, Y; Sun, A; Xu, F | 1 |
| Cao, WW; Cao, Y; Chang, BB; Chen, YC; Liu, XQ; Yang, WL; Zhang, L | 1 |
| Gao, C; Gao, Y; Li, X; Wei, S; Zhang, M; Zhong, L | 1 |
| Fuster, V; Moreno, PR; Sanz, J | 1 |
| Ferrari, LF; Green, PG; Joseph, EK; Levine, JD | 1 |
4 review(s) available for homocysteine and cardiovascular agents
| Article | Year |
|---|---|
[Risk management of coronary artery disease--pharmacological therapy].
Topics: Adrenergic beta-Antagonists; Aspirin; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Drug Therapy, Combination; Homocysteine; Humans; Nitroglycerin; Risk Factors | 2004 |
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
Topics: Animals; Atherosclerosis; Cardiovascular Agents; Cardiovascular Diseases; Endothelium, Vascular; Folic Acid; Heart Defects, Congenital; Hemodynamics; Homocysteine; Humans; Nitric Oxide; Nitric Oxide Synthase Type III | 2008 |
Plaque biology: interesting science or pharmacological treasure trove?
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Atherosclerosis; Biomarkers; Blood Coagulation; C-Reactive Protein; Cardiovascular Agents; Cytokines; Disease Progression; Hematologic Agents; Homocysteine; Humans; Hypolipidemic Agents; Inflammation; Intercellular Signaling Peptides and Proteins; Lipid Metabolism; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Protease Inhibitors; Signal Transduction | 2008 |
The year in atherothrombosis.
Topics: Animals; Atherosclerosis; Biomarkers; Cardiovascular Agents; Diabetes Complications; Dyslipidemias; Early Diagnosis; Fibrinolytic Agents; Global Health; Health Behavior; Health Care Costs; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Hypertension; Magnetic Resonance Imaging; Medication Adherence; Plaque, Atherosclerotic; Risk Factors; Risk Reduction Behavior; Stents; Thrombosis; United States | 2012 |
3 trial(s) available for homocysteine and cardiovascular agents
| Article | Year |
|---|---|
Effect of dexrazoxane on homocysteine-induced endothelial dysfunction in normal subjects.
Topics: Adult; Antioxidants; Blood Flow Velocity; Brachial Artery; Cardiovascular Agents; Chelating Agents; Cross-Over Studies; Endothelium, Vascular; Female; Homocysteine; Humans; Iron; Male; Methionine; Oxidative Stress; Razoxane | 2002 |
Role of folic acid in atherosclerosis after kidney transplant: a double-blind, randomized, placebo-controlled clinical trial.
Topics: Administration, Oral; Adult; Cardiovascular Agents; Carotid Artery Diseases; Carotid Artery, Common; Carotid Artery, Internal; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Time Factors; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography, Doppler | 2009 |
Randomized clinical trial of folate supplementation in patients with peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Ankle Brachial Index; Blood Flow Velocity; Cardiovascular Agents; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Intermittent Claudication; Male; Middle Aged; Tetrahydrofolates; Treatment Outcome | 2009 |
6 other study(ies) available for homocysteine and cardiovascular agents
| Article | Year |
|---|---|
Acute negative inotropic effects of homocysteine are mediated via the endothelium.
Topics: Animals; Cardiovascular Agents; Coronary Vessels; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Heart; Homocysteine; In Vitro Techniques; Indomethacin; Male; Myocardial Contraction; Nitroarginine; Octoxynol; Papillary Muscles; Rats; Rats, Sprague-Dawley | 2004 |
Beneficial effects of danshensu, an active component of Salvia miltiorrhiza, on homocysteine metabolism via the trans-sulphuration pathway in rats.
Topics: Animals; Cardiovascular Agents; Cysteine; Dose-Response Relationship, Drug; Glutathione; Homocysteine; Hyperhomocysteinemia; Lactates; Male; Methionine; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza | 2009 |
Heparin inhibits the production of matrix metalloproteinase-2 and improves atherosclerosis in LDL receptor-deficient mice.
Topics: Animals; Aorta; Atherosclerosis; Biomarkers; Body Weight; Cardiovascular Agents; Cholesterol; Cholesterol, HDL; Disease Models, Animal; Eating; Heparin; Homocysteine; Immunohistochemistry; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, LDL; Triglycerides | 2010 |
Using neural networks to determine the contribution of danshensu to its multiple cardiovascular activities in acute myocardial infarction rats.
Topics: Acute Disease; Algorithms; Animals; Area Under Curve; Cardiovascular Agents; Drugs, Chinese Herbal; Glutathione; Homocysteine; Lactates; Ligation; Male; Myocardial Infarction; Neural Networks, Computer; Phytotherapy; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Troponin T | 2011 |
Cystatin C levels are associated with the prognosis of systolic heart failure patients.
Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Agents; China; Cystatin C; Disease Progression; Female; Heart Failure, Systolic; Heart Transplantation; Homocysteine; Hospitals, University; Humans; Inflammation Mediators; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Up-Regulation | 2011 |
Homocysteine-induced attenuation of vascular endothelium-dependent hyperalgesia in the rat.
Topics: Analgesics, Non-Narcotic; Animals; Cardiovascular Agents; Disease Models, Animal; Endothelin-1; Endothelium, Vascular; Homocysteine; Hyperalgesia; Hypoxia-Ischemia, Brain; Male; Methionine; Movement; Muscle, Skeletal; Myalgia; Rats, Sprague-Dawley; Reflex Sympathetic Dystrophy; Touch; Vibration | 2015 |